placeholder image

L. E. Porter All authors

About

Publications While At HealthPartners

selected publications

Journal Article
  • Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial. 
  • Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study. 

    • Contact

    full name

  • L. E. Porter

    • Quick Info

    Publications

    Collaboration